APA (7th ed.) Citation

A, S., C, C., R, J., J, H., MA, T., L, K., . . . Z, A. (2019). Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction. The Lancet. Child & adolescent health, 3(3), e2. https://doi.org/10.1016/S2352-4642(19)30020-3

Chicago Style (17th ed.) Citation

A, Sharp, et al. "Mortality in the UK STRIDER Trial of Sildenafil Therapy for the Treatment of Severe Early-onset Fetal Growth Restriction." The Lancet. Child & Adolescent Health 3, no. 3 (2019): e2. https://doi.org/10.1016/S2352-4642(19)30020-3.

MLA (9th ed.) Citation

A, Sharp, et al. "Mortality in the UK STRIDER Trial of Sildenafil Therapy for the Treatment of Severe Early-onset Fetal Growth Restriction." The Lancet. Child & Adolescent Health, vol. 3, no. 3, 2019, p. e2, https://doi.org/10.1016/S2352-4642(19)30020-3.